Compare UNP & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UNP | PFE |
|---|---|---|
| Founded | 1862 | 1849 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Railroads | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.9B | 155.0B |
| IPO Year | 2004 | 2013 |
| Metric | UNP | PFE |
|---|---|---|
| Price | $251.93 | $27.13 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 23 | 12 |
| Target Price | ★ $261.68 | $27.83 |
| AVG Volume (30 Days) | 3.1M | ★ 32.8M |
| Earning Date | 04-28-2026 | 05-04-2026 |
| Dividend Yield | 2.17% | ★ 6.36% |
| EPS Growth | ★ 8.03 | N/A |
| EPS | ★ 11.98 | 1.36 |
| Revenue | $19,533,000,000.00 | ★ $62,579,000,000.00 |
| Revenue This Year | $4.22 | N/A |
| Revenue Next Year | $4.75 | N/A |
| P/E Ratio | $21.18 | ★ $19.88 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $204.66 | $20.92 |
| 52 Week High | $268.14 | $27.94 |
| Indicator | UNP | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 43.71 | 53.91 |
| Support Level | $217.95 | $24.99 |
| Resistance Level | $268.14 | $27.67 |
| Average True Range (ATR) | 5.23 | 0.54 |
| MACD | -2.63 | -0.08 |
| Stochastic Oscillator | 17.07 | 63.92 |
Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two-thirds of the US, Union Pacific generated $24 billion of revenue in 2024 by hauling coal, industrial products, intermodal containers, agricultural goods, chemicals, fertilizers, and automotive goods. Union Pacific owns about one-fourth of Mexican railroad Ferromex and historically derives roughly 10% of its revenue hauling freight to and from Mexico.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.